When We Tri(al) Our New Partner!
Our newest Metastatic Trial Search partner is WhenWeTrial.org. When We Tr(ial) is a collaboration between TOUCH, The Black Breast Cancer Alliance and...
Read MoreVirtual Conferences: How Do I Prepare?
Breast cancer conferences are currently in-person, virtual, or hybrid (both in-person and virtual). Conferences, regardless of the setting, are often free for...
Read MoreAll About Phase I Clinical Trials
Prior to FDA approval, the safety and effectiveness of drugs are tested in three main phases of clinical trials: phase I, II, and III. Phase I clinical trials...
Read MoreMale MBC Treatment And Clinical Trials
Over 2,700 men will be diagnosed with invasive breast cancer this year, and about 90% of male breast cancer is hormone-receptor-positive (ER+ and/or PR+). Doctors...
Read MoreMBCBrainMets.org – Our New Partner!
Our newest Metastatic Trial Search partner is MBCBrainMets.org. The new website was recently launched to fill an unmet need for information and support for people...
Read MoreBispecific Antibodies: An Emerging Class Of MBC Drugs
Bispecific antibodies are an emerging class of drugs in breast cancer clinical research. By binding to two distinct targets, a bispecific antibody can do two jobs...
Read MoreMBC and NED
The term No Evidence of Disease (NED) means that the cancer is not detectable in a person’s body with currently available tests such as imaging and blood...
Read More“Standard of Care” for MBC
“Standard of care” is the term used for the best existing treatment option in the clinic. Standard of care varies for different subtypes of MBC and is...
Read MoreTreatment for MBC While Pregnant
MBC is sometimes detected in pregnant women. Breast cancer does not pass to the unborn baby and does not harm the baby. There is no standard of care recommended...
Read MoreSEARCH OUR SITE
for past articles or specific information.